Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy--a case report and review of the literature.
van der Heijden
M
M
Department of Medical Oncology, Newcastle Mater Misericordiae Hospital Waratah, NSW, Australia.
Ackland
S P
SP
Deveridge
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy
D001761:Bleomycin; D015251:Epirubicin; D002945:Cisplatin